February 7, 2025 - 10:22

Hitachi has announced the establishment of a substantial $400 million venture capital fund, marking a significant milestone in its commitment to innovation and technology. This new fund elevates Hitachi's total corporate venture capital investments to an impressive $1 billion. The primary focus of this initiative will be on deep tech startups, particularly those working on groundbreaking advancements in quantum computing, artificial intelligence, and next-generation technologies.
The move reflects Hitachi's strategic vision to harness the potential of emerging technologies and support startups that are at the forefront of innovation. By investing in these sectors, Hitachi aims to foster collaboration and drive advancements that can lead to transformative solutions in various industries. The venture capital fund is expected to not only bolster Hitachi's portfolio but also contribute to the broader ecosystem of technological development, ensuring a competitive edge in the rapidly evolving global market.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...